Seelos Therapeutics, Inc. (SEEL): Price and Financial Metrics

Seelos Therapeutics, Inc. (SEEL): $0.66

-0.05 (-6.62%)

POWR Rating

Component Grades













Add SEEL to Watchlist
Sign Up

Industry: Biotech



in industry

SEEL Stock Price Chart Interactive Chart >

Price chart for SEEL

SEEL Price/Volume Stats

Current price $0.66 52-week high $3.10
Prev. close $0.71 52-week low $0.48
Day low $0.65 Volume 11,931,800
Day high $0.76 Avg. volume 1,650,903
50-day MA $0.65 Dividend yield N/A
200-day MA $1.35 Market Cap 70.14M

Seelos Therapeutics, Inc. (SEEL) Company Bio

Seelos Therapeutics, Inc. operates as a biotechnology company. The Company develops treatments for post-traumatic stress and major depressive disorders. Seelos Therapeutics serves patients in the United States.

SEEL Latest News Stream

Event/Time News Detail
Loading, please wait...

SEEL Latest Social Stream

Loading social stream, please wait...

View Full SEEL Social Stream

Latest SEEL News From Around the Web

Below are the latest news stories about Seelos Therapeutics Inc that investors may wish to consider to help them evaluate SEEL as an investment opportunity.

Psychedelic Stock Gainers And Losers From February 24, 2022

GAINERS: Seelos Therapeutics (NASDAQ: SEEL ) shares closed up 11.06% at $1.10 Mind Medicine (NASDAQ: MNMD ) shares closed up 11.01% at $1.21 Compass Pathways (NASDAQ: CMPS ) shares closed up 4.50% at $13.23 ATAI Life Sciences (NASDAQ: ATAI ) shares closed up 3.83% at $5.42 Mindset Pharma (OTC: Full story available on

Benzinga | February 24, 2022

B.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to Recover

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Seelos Therapeutics (SEEL – Research Report) today and set a price target of $6.00. The company's shares closed last Wednesday at $1.20, close to its 52-week low of $1.00. According to, Mamtani has 0 stars on 0-5 stars ranking scale with an average return of -19.6% and a 28.4% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals. Seelos Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.

Howard Kim on TipRanks | February 17, 2022

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC: Full story available on

Benzinga | February 3, 2022

Psychedelic Stock Gainers And Losers From January 20, 2022

GAINERS: Small Pharma (OTC: DMTTF ) shares closed up 14.55% at $0.21 GH Research (NASDAQ: GHRS ) shares closed up 3.35% at $16.99 Field Trip Health (NASDAQ: FTRP ) shares closed up 2.00% at $2.04 LOSERS: Mindset Pharma (OTC: MSSTF ) shares closed down -4.33% at $0.57 Seelos Therapeutics (NASDAQ: SEEL ) shares closed down Full story available on

Benzinga | January 20, 2022

Seelos Therapeutics, Inc. (NASDAQ:SEEL) Expected to Post Earnings of -$0.12 Per Share

Brokerages forecast that Seelos Therapeutics, Inc. (NASDAQ:SEEL) will report earnings per share of ($0.12) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Seelos Therapeutics earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.12). Seelos Therapeutics posted earnings per share of ($0.13) during the same []

Dakota Financial News | December 23, 2021

Read More 'SEEL' Stories Here

SEEL Price Returns

1-mo 7.13%
3-mo -23.56%
6-mo -60.00%
1-year -77.24%
3-year -71.55%
5-year -97.98%
YTD -59.51%
2021 3.16%
2020 17.91%
2019 -76.74%
2018 -89.57%
2017 41.54%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5319 seconds.